0.00Open0.00Pre Close0 Volume0 Open Interest8.00Strike Price0.00Turnover512.80%IV-67.36%PremiumJul 19, 2024Expiry Date3.22Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7142Delta0.1195Gamma1.33Leverage Ratio-0.0988Theta-0.0008Rho-0.95Eff Leverage0.0019Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet